Improving light stability by configuring active ingredients in the inner core: OSDrC technology and contract formulation development.
<Tablet Sample Presentation> Introducing the improvement of light stability using OSDrC technology! The outer layer's barrier effect protects the active ingredients from light.
The "OSDrC" technology allows for precise and flexible control of the inner core due to its variable double-structure design, enabling the production of higher quality core-containing tablets than ever before, as well as the development of various new dosage forms. By localizing the active ingredients in the inner core and physically protecting them with an outer layer, stability against light is improved. 【Features】 ■ The outer layer can be of any desired thickness. ■ It is possible to manufacture formulations that place light-sensitive active ingredients in the inner core and less light-sensitive active ingredients in the outer layer. * Data demonstrating the protective effect of active ingredients from light using OSDrC technology can be viewed by downloading from the special website below. ◎ Sample Offer ◎ For those interested, we will send samples of tablets made using OSDrC technology. Please indicate your request for samples and the quantity in the inquiry form below. *: One person's sample consists of two PTP packaged sheets (one sheet each of round tablets and oblong tablets). * For more details about OSDrC technology, please refer to the OSDrC main brochure available on the special website below, or feel free to contact us.
Inquire About This Product
basic information
Please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
Please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Sanwa Chemical Research Institute, as a member of the Suzuken Group focused on health creation, provides services aimed at improving the quality of life (QOL) for people who wish for better health, centered around its two main businesses: "pharmaceuticals" and "diagnostic drugs." In the "pharmaceuticals business," we are steadily building a track record with a focus on new drugs in the areas of diabetes and kidney/dialysis-related fields. In the "diagnostic drugs business," we are continuously developing and launching self-blood glucose meters, sensors, and diagnostic drugs for infectious diseases. Furthermore, by adding two more businesses— the "OSDrC (Osudrack) business" utilizing innovative formulation technology and the "contract manufacturing business" with advanced quality control systems— Sanwa Chemical Research Institute continues to evolve further.